Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
3,783 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Effectiveness of exergaming in reducing cancer-related fatigue among children with acute lymphoblastic leukemia: a randomized controlled trial.
Masoud AE, Shaheen AAM, Algabbani MF, et al. · Ann Med · 2023Randomized Controlled Trial
- Hyperlipidemia in children and adolescents with acute lymphoblastic leukemia: A systematic review and meta-analysis.
Laumann RD, Pedersen LL, Andrés-Jensen L, et al. · Pediatr Blood Cancer · 2023Systematic Review, Meta-Analysis
- Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review.
Koodrubiec J, Kozowska M, Irga-Jaworska N, et al. · Leuk Res · 2022Systematic Review, Research Support, Non-U.S. Gov't
- ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Østergaard A, Fiocco M, de Groot-Kruseman H, et al. · Leukemia · 2024Meta-Analysis, Research Support, Non-U.S. Gov't
- IKZF1 rs4132601 polymorphism and acute lymphoblastic leukemia susceptibility: a meta-analysis.
Li S, Ren L, Fan L, et al. · Leuk Lymphoma · 2015Meta-Analysis
- Prognostic significance of CRLF2 in patients with acute lymphoblastic leukemia: a meta-analysis and systematic review.
Meng Z, Zheng H, Liu Y, et al. · Ann Hematol · 2024Meta-Analysis, Systematic Review
- MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM, Hammad AM, Saad AM, et al. · Crit Rev Oncol Hematol · 2019Meta-Analysis, Systematic Review
- Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
Ferrari A, Ghelli Luserna Di Rora A, Domizio C, et al. · Br J Haematol · 2021Clinical Trial, Letter
- Prevalence of symptoms in children with acute lymphoblastic leukaemia: a systematic review and meta-analysis.
Lan X, Wu J, Liao Z, et al. · BMC Cancer · 2023Meta-Analysis, Systematic Review
- Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia.
Wei AH, Ribera JM, Larson RA, et al. · Leukemia · 2021Clinical Trial, Phase III, Randomized Controlled Trial
- Clinical, economic, and quality-of-life outcomes of brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma and B-cell acute lymphoblastic leukemia: A systematic literature review and meta-analysis.
Shah BD, Iloabuchi C, Harrigan S, et al. · J Manag Care Spec Pharm · 2026Systematic Review, Meta-Analysis
- Differences in efficacy and safety among CAR-Ts anti-CD19/CD22, anti-CD19, and anti-CD22, in adult patients with relapse/refractory B-cell acute lymphoblastic leukemia: a meta-analysis and systematic review.
Becerril-Rico J, Delgado-Montes YA, Ortiz-Sánchez E · Leuk Lymphoma · 2023Meta-Analysis, Systematic Review
- A systematic review and meta-analysis of the effectiveness of primary thromboprophylaxis in acute lymphoblastic leukemia during early-phase therapy including asparaginase or its prolonged form.
Hu Z, Persaud Y, Ahuja S · Crit Rev Oncol Hematol · 2024Systematic Review, Meta-Analysis
- The Efficacy of Pediatric-Inspired Regimens vs. Hyper-CVAD in the Treatment of Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
Su W, Stricherz M, Martin A, et al. · Am J Hematol · 2025Systematic Review, Meta-Analysis
- Association Between Maternal Infection During Pregnancy and the Risk of Childhood Acute Lymphoblastic Leukemia in Offspring: A Systematic Review and Meta-Analysis.
Chen X, Wang S, Yu W, et al. · Pediatr Blood Cancer · 2026Systematic Review, Meta-Analysis
- Secondary acute lymphoblastic leukemia, a retrospective analysis from Washington University and meta-analysis of published data.
Ferraro F, Gao F, Stockerl-Goldstein K, et al. · Leuk Res · 2018Meta-Analysis, Research Support, N.I.H., Extramural
- The prognostic implications of CDKN2A/2B deletion in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis.
Sarangarajan S, Meena JP, Gupta AK, et al. · Leuk Lymphoma · 2025Meta-Analysis, Systematic Review
- Non-relapse mortality in pediatric acute lymphoblastic leukemia: a systematic review and meta-analysis.
Blanco E, Beyene J, Maloney AM, et al. · Leuk Lymphoma · 2012Meta-Analysis, Research Support, Non-U.S. Gov't
- Comparison of third-generation tyrosine kinase inhibitor (TKI) ponatinib with first- and second-generation TKIs for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: A systematic review and bias-corrected meta-analysis.
Raza MZ, Khwaja HF, Arshad HME, et al. · Crit Rev Oncol Hematol · 2025Systematic Review, Meta-Analysis
- Pediatric acute lymphoblastic leukemia management using multitargeting bioactive natural compounds: A systematic and critical review.
Nabizadeh F, Momtaz S, Ghanbari-Movahed M, et al. · Pharmacol Res · 2022Systematic Review
- A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
Owattanapanich W, Leelakanok N, Sanpakit K, et al. · Clin Lymphoma Myeloma Leuk · 2022Meta-Analysis, Systematic Review
- Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis.
Srinivasan S, Ramanathan S, Kumar S, et al. · Ann Hematol · 2023Meta-Analysis, Systematic Review
- Osteoarticular manifestation of acute lymphoblastic leukemia in adults: a literature review.
Slouma M, Hannech E, Ghedira H, et al. · Clin Rheumatol · 2023Systematic Review, Case Reports
- The role of chemokines and interleukins in acute lymphoblastic leukemia: a systematic review.
Stajer M, Horacek JM, Kupsa T, et al. · J Appl Biomed · 2024Systematic Review
- Survival outcomes in secondary and primary acute lymphoblastic leukemia: a systematic review and meta-analysis.
Abedini F, Manteghinejad A, Rezaeian Z, et al. · Sci Rep · 2025Systematic Review, Meta-Analysis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.